2 Telehealth Stocks That Could Gain from Trump’s New FDA Pick
Jea Yu
Discover two telehealth stocks, Hims & Hers (HIMS) and Teladoc (TDOC), poised to benefit from Trump's FDA nominee, Dr. Marty Makary, a telemedicine advocate.
NYSE:HIMSNYSE:TDOCNYSE:LLY